According to the recent study
Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van
Wagoner DR, Psaty BM, Lauer MS, Chung MK. Inflammation as a risk factor for atrial fibrillation.
Circulation. 2003 Dec 16;108(24):3006-10. Epub 2003 Nov 17. PMID: 14623805 [PubMed - in process]
<URL:http://circ.ahajournals.org/cgi/content/abstract/108/24/3006>
the systemic inflammation determined by elevations in C-reactive protein (CRP) is associated with
the presence of atrial fibrillation and may also predict patients at increased risk for future
development of atrial fibrillation.
Abstract:
"BACKGROUND: The presence of systemic inflammation determined by elevations in C-reactive
protein (CRP) has been associated with persistence of atrial fibrillation (AF). The
relationship between CRP and prediction of AF has not been studied in a large population-based
cohort. METHODS AND RESULTS: CRP measurement and cardiovascular assessment were performed at
baseline in 5806 subjects enrolled in the Cardiovascular Health Study. Patients were followed
up for a mean of 6.9+/-1.6 (median 7.8) years. AF was identified by self-reported history and
ECGs at baseline and by ECGs and hospital discharge diagnoses at follow-up. Univariate and
multivariate analyses were used to assess CRP as a predictor of baseline and future development
of AF. At baseline, 315 subjects (5%) had AF. Compared with subjects in the first CRP quartile
(<0.97 mg/L), subjects in the fourth quartile (>3.41 mg/L) had more AF (7.4% versus 3.7%,
adjusted OR 1.8, 95% CI 1.2 to
2.5; P=0.002). Of 5491 subjects without AF at baseline, 897 (16%) developed AF during follow-up.
Baseline CRP predicted higher risk for developing future AF (fourth versus first quartile
adjusted hazard ratio 1.31, 95% CI 1.08 to 1.58; P=0.005). When treated as a continuous
variable, elevated CRP predicted increased risk for developing future AF (adjusted hazard
ratio for 1-SD increase, 1.24; 95% CI 1.11 to 1.40; P<0.001). CONCLUSIONS: CRP is not only
associated with the presence of AF but may also predict patients at increased risk for future
development of AF."
--
Matti Narkia